RGEN

#1089
Repligen Corp
125.3500 USD
+2.25%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
125.1650
126.5100
Intervallo Annuale
109.6600
175.5700
Variazione giornaliera
+2.25%
Variazione Mensile
+8.70%
Variazione di 6 mesi
-24.35%
Variazione Annuale
-24.35%
Chiusura Precedente
122.5900
Apertura
125.5500
Bid
Ask
Minimo
125.1650
High
126.5100
Volume
41
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 7.0611 B
  • Employee 2 000
  • Founded 1981
  • CEO Tony J. Hunt
  • Website www.repligen.com
  • Headquarter Delaware, United States
  • FIGI BBG000BS48J3
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
190.53
Rapporto prezzo/fatturato
0.01

Repligen Corporation

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

Notizie